In a statement, APA President John Oldham, M.D., said the article “does not take into account the level to which DSM-5 Task Force and work group members have minimized or divested themselves from relationships with the pharmaceutical industry.”
The article, “A Comparison of DSM-IV and DSM-5 Panel Members’ Financial Associations With Industry: A Pernicious Problem Persists,” can be accessed here. Oldham’s response is on the APA Web site here. For information about the DSM-5 financial disclosure policy, see Psychiatric News here.
(Image: kentoh/Shutterstock.com)